193 related articles for article (PubMed ID: 28251953)
21. [Recombinant cephalosporin-acid synthesase: optimisation of expression in E.coli cells, immobilisation and application for biocatalytic cefazolin synthesis].
Eldarov MA; Sklyarenko AV; Dumina MV; Medvedeva NV; Jgoun AA; Satarova JE; Sidorenko AI; Emperian AS; Yarotsky SV
Biomed Khim; 2015; 61(5):646-51. PubMed ID: 26539875
[TBL] [Abstract][Full Text] [Related]
22. RrA, an enzyme from Rhodospirillum rubrum, is a prototype of a new family of short-chain L-asparaginases.
Zhang D; Czapinska H; Bochtler M; Wlodawer A; Lubkowski J
Protein Sci; 2024 Apr; 33(4):e4920. PubMed ID: 38501449
[TBL] [Abstract][Full Text] [Related]
23. The differential ability of asparagine and glutamine in promoting the closed/active enzyme conformation rationalizes the Wolinella succinogenes L-asparaginase substrate specificity.
Nguyen HA; Durden DL; Lavie A
Sci Rep; 2017 Jan; 7():41643. PubMed ID: 28139703
[TBL] [Abstract][Full Text] [Related]
24. PEG-chitosan and glycol-chitosan for improvement of biopharmaceutical properties of recombinant L-asparaginase from Erwinia carotovora.
Sukhoverkov KV; Kudryashova EV
Biochemistry (Mosc); 2015 Jan; 80(1):113-9. PubMed ID: 25754046
[TBL] [Abstract][Full Text] [Related]
25. Novel mutant of Escherichia coli asparaginase II to reduction of the glutaminase activity in treatment of acute lymphocytic leukemia by molecular dynamics simulations and QM-MM studies.
Ardalan N; Mirzaie S; Sepahi AA; Khavari-Nejad RA
Med Hypotheses; 2018 Mar; 112():7-17. PubMed ID: 29447943
[TBL] [Abstract][Full Text] [Related]
26. Hyperthermophilic asparaginase mutants with enhanced substrate affinity and antineoplastic activity: structural insights on their mechanism of action.
Bansal S; Srivastava A; Mukherjee G; Pandey R; Verma AK; Mishra P; Kundu B
FASEB J; 2012 Mar; 26(3):1161-71. PubMed ID: 22166247
[TBL] [Abstract][Full Text] [Related]
27. L-Asparaginase from Erwinia Chrysanthemi 3937: cloning, expression and characterization.
Kotzia GA; Labrou NE
J Biotechnol; 2007 Jan; 127(4):657-69. PubMed ID: 16984804
[TBL] [Abstract][Full Text] [Related]
28. Cloning and characterization of Halomonas elongata L-asparaginase, a promising chemotherapeutic agent.
Ghasemi A; Asad S; Kabiri M; Dabirmanesh B
Appl Microbiol Biotechnol; 2017 Oct; 101(19):7227-7238. PubMed ID: 28801829
[TBL] [Abstract][Full Text] [Related]
29. A structural in silico analysis of the immunogenicity of l-asparaginase from Escherichia coli and Erwinia carotovora.
Belén LH; Lissabet JB; de Oliveira Rangel-Yagui C; Effer B; Monteiro G; Pessoa A; Farías Avendaño JG
Biologicals; 2019 May; 59():47-55. PubMed ID: 30871932
[TBL] [Abstract][Full Text] [Related]
30. Helicobacter pyloril-asparaginase: a promising chemotherapeutic agent.
Cappelletti D; Chiarelli LR; Pasquetto MV; Stivala S; Valentini G; Scotti C
Biochem Biophys Res Commun; 2008 Dec; 377(4):1222-6. PubMed ID: 18983825
[TBL] [Abstract][Full Text] [Related]
31. [Oligomerization of L-asparaginase from Erwinia carotovora].
Mezentsev IuV; Mol'nar AA; Gnedenko OV; Krasotkina IuV; Sokolov NN; Ivanov AS
Biomed Khim; 2006; 52(3):258-71. PubMed ID: 16898584
[TBL] [Abstract][Full Text] [Related]
32. [Bacterial L-asparaginase and glutamin(asparagin)ase: some properties, structure and anti-tumor activity].
Sokolov NN; Zanin VA; Aleksandrova SS
Vopr Med Khim; 2000; 46(6):531-48. PubMed ID: 11234278
[TBL] [Abstract][Full Text] [Related]
33. A novel type IIb L-asparaginase from Latilactobacillus sakei LK-145: characterization and application.
Kato S; Tamura K; Masuda Y; Konishi M; Yamanaka K; Oikawa T
Arch Microbiol; 2024 May; 206(6):266. PubMed ID: 38761213
[TBL] [Abstract][Full Text] [Related]
34. A critical review on properties and applications of microbial l-asparaginases.
Krishnapura PR; Belur PD; Subramanya S
Crit Rev Microbiol; 2016 Sep; 42(5):720-37. PubMed ID: 25865363
[TBL] [Abstract][Full Text] [Related]
35. A protease-resistant Escherichia coli asparaginase with outstanding stability and enhanced anti-leukaemic activity in vitro.
Maggi M; Mittelman SD; Parmentier JH; Colombo G; Meli M; Whitmire JM; Merrell DS; Whitelegge J; Scotti C
Sci Rep; 2017 Nov; 7(1):14479. PubMed ID: 29101342
[TBL] [Abstract][Full Text] [Related]
36. [Purification and properties of recombinant Erwinia carotovora L-asparaginase expressed in E.coli cells].
Borisova AA; El'darov MA; Zhgun AA; Aleksandrova SS; Omel'ianiuk NM; Sokov BN; Berezov TT; Sokolov NN
Biomed Khim; 2003; 49(5):502-7. PubMed ID: 16119104
[TBL] [Abstract][Full Text] [Related]
37. Improvement of stability and enzymatic activity by site-directed mutagenesis of E. coli asparaginase II.
Verma S; Mehta RK; Maiti P; Röhm KH; Sonawane A
Biochim Biophys Acta; 2014 Jul; 1844(7):1219-30. PubMed ID: 24721562
[TBL] [Abstract][Full Text] [Related]
38. Amino acid residues adjacent to the catalytic cavity of tetramer L-asparaginase II contribute significantly to its catalytic efficiency and thermostability.
Long S; Zhang X; Rao Z; Chen K; Xu M; Yang T; Yang S
Enzyme Microb Technol; 2016 Jan; 82():15-22. PubMed ID: 26672444
[TBL] [Abstract][Full Text] [Related]
39. Expression, purification, and characterization of asparaginase II from Saccharomyces cerevisiae in Escherichia coli.
Lopes W; Santos BAFD; Sampaio ALF; Gregório Alves Fontão AP; Nascimento HJ; Jurgilas PB; Torres FAG; Bon EPDS; Almeida RV; Ferrara MA
Protein Expr Purif; 2019 Jul; 159():21-26. PubMed ID: 30836141
[TBL] [Abstract][Full Text] [Related]
40. Three-dimensional structures of L-asparaginase from Erwinia carotovora complexed with aspartate and glutamate.
Kravchenko OV; Kislitsin YA; Popov AN; Nikonov SV; Kuranova IP
Acta Crystallogr D Biol Crystallogr; 2008 Mar; 64(Pt 3):248-56. PubMed ID: 18323619
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
